KREBS BIOCHEMICALS & INDUSTRIES
Back to Balance Sheet
|
KREBS BIOCHEMICALS & INDUSTRIES Last 5 Year Total Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹104 Cr | ₹62 Cr | ₹49 Cr | ₹78 Cr | ₹48 Cr |
What is the latest Total Current Liabilities ratio of KREBS BIOCHEMICALS & INDUSTRIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹104 Cr |
| Mar2024 | ₹62 Cr |
| Mar2023 | ₹49 Cr |
| Mar2022 | ₹78 Cr |
| Mar2021 | ₹48 Cr |
How is Total Current Liabilities of KREBS BIOCHEMICALS & INDUSTRIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹104 Cr | 67.43 | |
| Mar2024 | ₹62 Cr | 25.92 | |
| Mar2023 | ₹49 Cr | -37.10 | |
| Mar2022 | ₹78 Cr | 61.99 | |
| Mar2021 | ₹48 Cr | - | |
Compare Total Current Liabilities of peers of KREBS BIOCHEMICALS & INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KREBS BIOCHEMICALS & INDUSTRIES | ₹131.5 Cr | 4.6% | 14.9% | -25.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹401,937.0 Cr | -1.4% | -7.2% | 0.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹165,359.0 Cr | 5.7% | 0.3% | 14.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,431.0 Cr | 1.5% | -6.5% | 28.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,114.0 Cr | 0.7% | -7.4% | 9.9% | Stock Analytics | |
| CIPLA | ₹100,028.0 Cr | 0.5% | -7.1% | -14.4% | Stock Analytics | |
KREBS BIOCHEMICALS & INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KREBS BIOCHEMICALS & INDUSTRIES | 4.6% |
14.9% |
-25.4% |
| SENSEX | 2.4% |
3.2% |
5.8% |
You may also like the below Video Courses